These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 10406680)

  • 1. Coated and active stents: an introduction.
    van der Giessen WJ; Schwartz RS
    Semin Interv Cardiol; 1998; 3(3-4):125-6. PubMed ID: 10406680
    [No Abstract]   [Full Text] [Related]  

  • 2. Metallic surface modification.
    De Scheerder I; Verbeken E; Van Humbeeck J
    Semin Interv Cardiol; 1998; 3(3-4):139-44. PubMed ID: 10406683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptomatic myocardial bridging--a niche indication for drug-eluting stents?
    Ng E; Jilaihawi H; Gershlick AH
    Int J Cardiol; 2005 Mar; 99(3):463-4. PubMed ID: 15771929
    [No Abstract]   [Full Text] [Related]  

  • 4. Stent coatings.
    Sigwart U; Prasad S; Radke P; Nadra I
    J Invasive Cardiol; 2001 Feb; 13(2):141-2; discussion 158-70. PubMed ID: 11176027
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthetic polymers.
    van Beusekom HM; Schwartz RS; van der Giessen WJ
    Semin Interv Cardiol; 1998; 3(3-4):145-8. PubMed ID: 10406684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The driver stent for coronary bifurcations: a clinical case and bench testing of provisional "culotte" side-branch stenting.
    Ormiston JA; Currie E; Panther MJ; Webster MW; O'Shaughnessy B
    J Invasive Cardiol; 2004 Feb; 16(2):1-3; quiz 4. PubMed ID: 14986621
    [No Abstract]   [Full Text] [Related]  

  • 7. Coronary stents: a materials perspective.
    Mani G; Feldman MD; Patel D; Agrawal CM
    Biomaterials; 2007 Mar; 28(9):1689-710. PubMed ID: 17188349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local methylprednisolone delivery using a BiodivYsio phosphorylcholine-coated drug-delivery stent reduces inflammation and neointimal hyperplasia in a porcine coronary stent model.
    Huang Y; Liu X; Wang L; Verbeken E; Li S; De Scheerder I
    Int J Cardiovasc Intervent; 2003; 5(3):166-71. PubMed ID: 12959735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylcholine-coated stents in porcine coronary arteries: in vivo assessment of biocompatibility.
    Malik N; Gunn J; Shepherd L; Crossman DC; Cumberland DC; Holt CM
    J Invasive Cardiol; 2001 Mar; 13(3):193-201. PubMed ID: 11231644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of molecular events in coronary restenosis using coated stents: The Mayo Clinic Approach.
    Keelan PC; Miyauchi K; Caplice NM; Ashai KH; Schwartz RS
    Semin Interv Cardiol; 1998; 3(3-4):211-5. PubMed ID: 10406696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-eluting balloons for percutaneous coronary interventions.
    Zimarino M; De Caterina R
    Thromb Haemost; 2009 Jan; 101(1):9-11. PubMed ID: 19132182
    [No Abstract]   [Full Text] [Related]  

  • 12. Reduction of subacute stent thrombosis (SAT) using heparin-coated stents in a large-scale, real world registry.
    Gupta V; Aravamuthan BR; Baskerville S; Smith SK; Gupta V; Lauer MA; Fischell TA
    J Invasive Cardiol; 2004 Jun; 16(6):304-10. PubMed ID: 15155999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue ingrowth in a fully covered self-expandable metallic stent (with videos).
    Jaganmohan S; Raju GS
    Gastrointest Endosc; 2008 Sep; 68(3):602-4. PubMed ID: 18331738
    [No Abstract]   [Full Text] [Related]  

  • 14. Coated stents: local pharmacology.
    Raman VK; Edelman ER
    Semin Interv Cardiol; 1998; 3(3-4):133-7. PubMed ID: 10406682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stent-based delivery of ABT-578 via a phosphorylcholine surface coating reduces neointimal formation in the porcine coronary model.
    Collingwood R; Gibson L; Sedlik S; Virmani R; Carter AJ
    Catheter Cardiovasc Interv; 2005 Jun; 65(2):227-32. PubMed ID: 15900559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycophenolic acid-eluting stent and the ABC's of stent-based immunosuppressive therapies for the prevention of restenosis.
    Carter AJ
    Catheter Cardiovasc Interv; 2005 Dec; 66(4):496-8. PubMed ID: 16283681
    [No Abstract]   [Full Text] [Related]  

  • 17. Silicon-carbide coated coronary stents have low platelet and leukocyte adhesion during platelet activation.
    Monnink SH; van Boven AJ; Peels HO; Tigchelaar I; de Kam PJ; Crijns HJ; van Oeveren W
    J Investig Med; 1999 Jul; 47(6):304-10. PubMed ID: 10431485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of nanoscale poly[bis(trifluoroethoxy) phosphazene] (PTFEP) coatings in reducing thrombogenicity and late in-stent stenosis in a porcine coronary artery model.
    Satzl S; Henn C; Christoph P; Kurz P; Stampfl U; Stampfl S; Thomas F; Radeleff B; Berger I; Grunze M; Richter GM
    Invest Radiol; 2007 May; 42(5):303-11. PubMed ID: 17414526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term biocompatibility evaluation of a novel polymer-coated stent in a porcine coronary stent model.
    Huang Y; Liu X; Wang L; Li S; Verbeken E; De Scheerder I
    Coron Artery Dis; 2003 Aug; 14(5):401-8. PubMed ID: 12878906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymer-sirolimus-eluting stents in de novo lesions.
    Schuler G
    Herz; 2004 Mar; 29(2):152-61. PubMed ID: 15057437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.